Recent Findings on Ketamine’s Efficacy in Treating Severe Depression

Recent Findings on Ketamine’s Efficacy in Treating Severe Depression

Researchers from the University of New South Wales and the affiliated Black Dog Institute have recently unveiled results from a pivotal double-blind trial in the British Journal of Psychiatry:

Study Highlights:

  • 179 participants with treatment-resistant depression were recruited.
  • Over 20% achieved total symptom remission with bi-weekly injections of a low-cost version of ketamine for one month.
  • A third saw their symptoms improve by at least 50%.
  • In comparison to the 20% remission rate in the ketamine group, only 2% in the placebo group reported such results, marking a significant difference.

Methodological Notables:

  • The trial included participants who had undergone electroconvulsive therapy (ECT), a rare approach in such studies.
  • The administration was subcutaneous, simplifying the process compared to traditional drips.
  • Midazolam, a sedative, was used as the placebo to ensure better blinding.

The researchers advocate for broader Medicare support given the treatment’s potential. Further trials and safety monitoring refinements are underway.

Share Post :

Request An Appointment

Ketamine Treatments


Have a question or need to schedule an appointment? Give us a call now.

Related Post

What is Behavioral Health? - Luvita Ketamine in Helena, MT
Mental Health

What is Behavioral Health?

Behavioral health is an integral part of our overall well-being. It encompasses various aspects of our mental and emotional health, as well as our behaviors

Read More »
Call Now